• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • UK / Ireland

Q&A: Tommy Seddon, Riverside

Tommy Seddon of Riverside
  • Alice Murray
  • Alice Murray
  • 28 March 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Having recently joined Riverside’s origination team from DC Advisory, Tommy Seddon speaks to Alice Murray about finding quality deals in the increasingly competitive UK mid-market

Alice Murray: What are the key sources of new deal opportunities in the UK at the moment?

Tommy Seddon: We've seen a really good raft of opportunities from all sources; from owner-managed businesses and from financial sponsors. We can rule out take-private deals as the equity markets have been cooking over the last few months.

There has been lots of doom and gloom in the headlines but we are taking joy in working with strong businesses and good management teams. There is a good mix of opportunities for private businesses. We're seeing strong companies coming through with solid trading after the recession. For a lot of businesses today, it's no longer about damage limitation – they're much stronger.

AM: What sectors are you focusing on and what are their main attractions?

TS: We target businesses with global ambition and this strategy supports certain sectors; those that are borderless. Riverside has completed a broad range of deals, and most of those fall under one of our eight industry specialisations.

In the UK, we're seeing many interesting tech deals and very compelling consumer goods deals. The market is strong for companies with good brands, like Tyrrells English Crisps or Fever Tree. We've also seen German confectionery coatings specialist Capol and Italian swimwear producer Arena generate nice returns and we are excited about our recent purchase of Mec3, an Italian gelato ingredients company.

There are certain niches within the technology sector where multiples are looking pricey, and that's reflective of the fast growth in this market. When looking at valuations, the focus should be on a company's defensible thesis, which means investors have to work harder and really know what they're getting into.

More broadly, Riverside has a strong record in healthcare in addition to education & training and energy. These are typically business areas that see beyond borders.

What's really great is seeing the global connectivity across Riverside. Last week I was speaking to the team in Japan about strong British brands that are traveling well. Our global presence allows us to test the global case. This allows us to see beyond sectors.

AM: How competitive is the market today and how do you differentiate yourself from other players?

TS: It is very competitive today. For our market segment, we're able to differentiate ourselves because of our global reach.

We are competitive because we are deliberately seeking out businesses with global ambition. So if we're not the best owner of a certain asset then we will walk away from the process.

AM: Has the increased competition for quality assets impacted pricing?

TS: In the lower mid-market there is still lots of value to be had. We target little leaders in their respective niches, with a road map for further growth.

It does feel as if pricing is increasing at times; we often hear about valuations that we don't understand. But this is only for good businesses. For strong assets, stability of earnings means that investors will pay a premium. However, we seek ambitious companies.

Once you get past a certain level of earnings, the lending market is more competitive and that increases pressure on pricing. Fortunately, we sit below that invisible cut-off point.

AM: Are vendor price expectations meeting sellers' expectations?

TS: Perhaps there has been an increase in the number of processes that don't find funding.

Vendors are more sophisticated in what they seek from a partner. People are very careful to find the right partner, so it's much more about what you can offer in terms of support for the business – it's not just about blind equity. This is where we can be competitive; we have operating partners, we provide support to CEOs through the Riverside University and we can pool our global expertise.

Trust is very important. We genuinely seek to partner with businesses and put a lot of emphasis on being supportive and sympathetic investors. We know what businesses need and we know how to take them to the next level. Without that support the business might not flourish.

AM: Riverside has a very unique approach to origination, how does it work on a day-to-day basis?

TS: We have a team of more than 20 people across four continents dedicated to origination. The team co-ordinates itself globally. We're out there trying to meet as many businesses as possible and team members that find opportunities champion those deals through to the investment stage. We also work alongside the research team in mapping out markets and pin-pointing attractive assets. It's about strategic thinking so that we go out as an informed investor.

We looked at around 5,000 deals last year and because of this high volume we need to be able to sift through them quickly and make sure we're looking at the best opportunities. In a competitive situation it is of huge value that we can execute quickly. Our origination team can assess opportunities very quickly, so moving from the point at which we encounter an opportunity to the point the transaction is carried out is done as quickly as possible.

We also leverage our global footprint for add-on opportunities. We work alongside portfolio companies to find the best assets and support acquisitive growth, and they can be anywhere in the world! If it's the right company, we'll get the deal done.

We're not entirely unique in this model but our main differentiator is that we have been doing this for more than 20 years.

AM: Do you use the advisory community for finding new deal opportunities?

TS: We're very lucky in that we have good relationships throughout the advisory community. The UK mid-market is very well intermediated and it is rare to find a completely proprietary deal.

We value the loyalty and sense of trust we have with our advisers. We have certain advisers that we are closer to; people we have partnered with over the 25 years we have been operating. We act in a responsible manner so that advisers can be sure of our behaviour; that we will give straight answers. If an adviser understands us, that can only be helpful as it's a third-party reference.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Buyouts
  • Consumer
  • Technology
  • Healthcare
  • Riverside
  • United Kingdom
  • Top story

More on UK / Ireland

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013